PremiumALMS

Young biotech company with insiders who keep buying

A consistent buying pattern by a director in a young biotech company signals high confidence in its future potential.

By the SpyStocks desk · · 1 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Good intel travels.

Share this story

Alumis: director buys $10 million after a plunge

PremiumInsidersALMS5h ago2 min read

Unusual insider buying alert!

PremiumInsidersAMRC6h ago2 min read

Fund manager sold $5.9 million in shares and returned to buy at a third of the price

PremiumInsidersLMB7h ago2 min read